Cortendo Enters Into Agreements to Acquire Aspireo Pharmaceuticals’ Somatoprim (DG3173) and In-License Antisense Therapeutics’ ATL1103 Cortendo Expands Investor Base Through New Private Placement May 15, 2015 – Göteborg, Sweden and Trevose, Pa., USA –...
Dr. Larry Hsu Elected to Board of Directors Menlo Park, CA – February 5, 2015 – Armetheon, Inc., a cardiovascular disease-focused, clinical stage, specialty biopharmaceutical company, today announced the successful closing of $24.3 million in Series B financing. The...
Archive Senesco Completes Acquisition of Fabrus Press Release May 19, 2014 8:30 am BRIDGEWATER, N.J.–(BUSINESS WIRE)– Senesco Technologies, Inc. (“Senesco” or the “Company”) (SNTI), completed its acquisition of Fabrus, Inc. (“Fabrus”), a biotechnology...
